Birmingham Mayor Randall Woodfin spoke on CNN Thursday, discussing President Donald Trump's executive orders and his views on how they might impact the city.

President Donald Trump issued an executive order titled “Ending Illegal Discrimination and Restoring Merit-Based Opportunity.” The executive order’s stated purpose is to end “illegal” diversity, ...

Army and Air Force officials were instructed to remove diversity, equity, inclusion-related communications, policies and training.

The University of Colorado Boulder appears to have deleted its Diversity, Equity and Inclusion — commonly referred to as DEI — as of Wednesday afternoon. University of Colorado system counterpart, CU ...

A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of ...

VERIFY readers asked if workers were really told they would face “adverse consequences” if they did not help identify “disguised” diversity and inclusion roles.

Then comes the CIF State Cheer Invitational on Feb. 1 at Mira Costa High in Manhattan Beach, then the National High School Cheer Championships at Walt Disney World in Orlando, Fla., Feb. 7 and 8. The ...

Shortly after his swearing in, President Donald Trump reinstated his ban on diversity, equity and inclusion (DEI) in the federal government. The move was a much-needed correction to former President ...

DEI has its defenders at Costco. Shareholders rejected--by a vote tally of around 98% to 2%--a proposal by a conservative activist group pushing the company to revisit its DEI policies. While many ...

The senator said at a news conference at Mother Bethel AME that he's confident the legislature and Gov. Shapiro will maintain the state's DEI initiatives despite an order from President Trump.

Longtime federal workers say they have become pawns in a battle for political control, that their DEI work is misunderstood and they fear they're under surveillance.

Following the Trump administration's DEI ban, the FDA's move to scrub webpages has ensnared many pages focused on ensuring diversity in drug trials.